BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29858790)

  • 1. Ex Vivo Radiolabeling and In Vivo PET Imaging of T Cells Expressing Nuclear Reporter Genes.
    Moroz MA; Zanzonico P; Lee JT; Ponomarev V
    Methods Mol Biol; 2018; 1790():153-163. PubMed ID: 29858790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging T Cell Dynamics and Function Using PET and Human Nuclear Reporter Genes.
    Lee JT; Moroz MA; Ponomarev V
    Methods Mol Biol; 2018; 1790():165-180. PubMed ID: 29858791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging.
    Dobrenkov K; Olszewska M; Likar Y; Shenker L; Gunset G; Cai S; Pillarsetty N; Hricak H; Sadelain M; Ponomarev V
    J Nucl Med; 2008 Jul; 49(7):1162-70. PubMed ID: 18552144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidine Kinase PET Reporter Gene Imaging of Cancer Cells In Vivo.
    McCracken MN
    Methods Mol Biol; 2018; 1790():137-151. PubMed ID: 29858789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes.
    Krebs S; Ahad A; Carter LM; Eyquem J; Brand C; Bell M; Ponomarev V; Reiner T; Meares CF; Gottschalk S; Sadelain M; Larson SM; Weber WA
    J Nucl Med; 2018 Dec; 59(12):1894-1900. PubMed ID: 29903928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes.
    Moroz MA; Zhang H; Lee J; Moroz E; Zurita J; Shenker L; Serganova I; Blasberg R; Ponomarev V
    J Nucl Med; 2015 Jul; 56(7):1055-60. PubMed ID: 26025962
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Mowday AM; Copp JN; Syddall SP; Dubois LJ; Wang J; Lieuwes NG; Biemans R; Ashoorzadeh A; Abbattista MR; Williams EM; Guise CP; Lambin P; Ackerley DF; Smaill JB; Theys J; Patterson AV
    Theranostics; 2020; 10(23):10548-10562. PubMed ID: 32929365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in PET Detection of the Antitumor T Cell Response.
    McCracken MN; Tavaré R; Witte ON; Wu AM
    Adv Immunol; 2016; 131():187-231. PubMed ID: 27235684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives.
    Viola-Villegas NT; Sevak KK; Carlin SD; Doran MG; Evans HW; Bartlett DW; Wu AM; Lewis JS
    Mol Pharm; 2014 Nov; 11(11):3965-73. PubMed ID: 24779727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Efficacy and Sensitivity of Alternative PET Reporter Gene/PET Reporter Probe Systems That Minimize Biological Variables.
    Xu S; Herschman HR
    Methods Mol Biol; 2020; 2126():177-190. PubMed ID: 32112389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer.
    Glumac PM; Gallant JP; Shapovalova M; Li Y; Murugan P; Gupta S; Coleman IM; Nelson PS; Dehm SM; LeBeau AM
    Clin Cancer Res; 2020 Mar; 26(5):1054-1064. PubMed ID: 31732520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8
    Seo JW; Tavaré R; Mahakian LM; Silvestrini MT; Tam S; Ingham ES; Salazar FB; Borowsky AD; Wu AM; Ferrara KW
    Clin Cancer Res; 2018 Oct; 24(20):4976-4987. PubMed ID: 29967252
    [No Abstract]   [Full Text] [Related]  

  • 13. The PET-Tracer
    Griessinger CM; Olafsen T; Mascioni A; Jiang ZK; Zamilpa C; Jia F; Torgov M; Romero JM; Marchioni F; Satpayev D; Lee C; Zhang G; Nayak TK; Pincha M; Amann M; Mohan PLB; Richard M; Nicolini VG; Sam J; Claus C; Ferrara C; Brünker P; Bacac M; Umana P; Rüttinger D; Wilson IA; Gudas J; Klein C; Tessier JJL
    Cancer Res; 2020 Jul; 80(13):2903-2913. PubMed ID: 32409308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive noninvasive monitoring of HSV1-tk-expressing T cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography with 18F-FEAU.
    Dotti G; Tian M; Savoldo B; Najjar A; Cooper LJ; Jackson J; Smith A; Mawlawi O; Uthamanthil R; Borne A; Brammer D; Paolillo V; Alauddin M; Gonzalez C; Steiner D; Decker WK; Marini F; Kornblau S; Bollard CM; Shpall EJ; Gelovani JG
    Mol Imaging; 2009; 8(4):230-7. PubMed ID: 19728977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging.
    McCracken MN; Vatakis DN; Dixit D; McLaughlin J; Zack JA; Witte ON
    J Clin Invest; 2015 May; 125(5):1815-26. PubMed ID: 25822024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy.
    Lu D; Wang Y; Zhang T; Wang F; Li K; Zhou S; Zhu H; Yang Z; Liu Z
    J Nanobiotechnology; 2021 Jun; 19(1):175. PubMed ID: 34112200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET Reporter Gene Imaging and Ganciclovir-Mediated Ablation of Chimeric Antigen Receptor T Cells in Solid Tumors.
    Murty S; Labanieh L; Murty T; Gowrishankar G; Haywood T; Alam IS; Beinat C; Robinson E; Aalipour A; Klysz DD; Cochran JR; Majzner RG; Mackall CL; Gambhir SS
    Cancer Res; 2020 Nov; 80(21):4731-4740. PubMed ID: 32958548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
    Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
    J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography.
    Long Y; Lv X; Song X; Shao F; Ji H; Zhang Y; Qiao P; Liu Q; Xia X; Lei P; Gai Y; Lan X
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4156-4170. PubMed ID: 35790537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen.
    Shu CJ; Radu CG; Shelly SM; Vo DD; Prins R; Ribas A; Phelps ME; Witte ON
    Int Immunol; 2009 Feb; 21(2):155-65. PubMed ID: 19106231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.